evaluate the pharmaceuticals company wegovy on glp-1 efficacy / effectiveness Market Overview: Agonists and Obesity Market | Blog Wegovy® pill demonstrated greater weight

Available at: (Accessed: 13 October 2025)

The NLRBs New Focus (July 2013)

doi:10.1002/dmrr.3699 Fitzgerald, J

Most common (especially in first 4-8 weeks): Nausea Early fullness/satiety Constipation Mild reflux or burping Less common but important: Severe nausea preventing adequate eating or drinking Gallbladder issues (rapid weight loss increases gallstone risk) Pancreatitis (rare, more common with high triglycerides or gallstone history) Dehydration The side effect no one mentions: Undereating

u , Change in body weight

For example, if you normally inject your semaglutide on Mondays but need to change it to Wednesdays, you could take your normal dose on Monday and then dose again on Wednesday